Prognoses of patients undergoing hemodialysis administered 23-valent pneumococcal polysaccharide versus 13-valent pneumococcal protein conjugate vaccines.

Yamaguchi, Kosei; Kitamura, Mineaki; Takazono, Takahiro; Hashiguchi, Junichiroh; Funakoshi, Satoshi; Mukae, Hiroshi; Nishino, Tomoya

Yamaguchi, Kosei; Kitamura, Mineaki; Takazono, Takahiro; Hashiguchi, Junichiroh; Funakoshi, Satoshi; Mukae, Hiroshi; Nishino, Tomoya.

Afiliación

Yamaguchi K; Department of Nephrology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan; Nagasaki Renal Center, Nagasaki, Japan.
Kitamura M; Department of Nephrology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan; Nagasaki Renal Center, Nagasaki, Japan. Electronic address: mineaki82@yahoo.co.jp.
Takazono T; Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Hashiguchi J; Nagasaki Renal Center, Nagasaki, Japan.
Funakoshi S; Nagasaki Renal Center, Nagasaki, Japan.
Mukae H; Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Nishino T; Department of Nephrology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.

J Infect Chemother ; 29(12): 1126-1131, 2023 Dec.

Article en En | MEDLINE | ID: mdl-37604429

Palabras clave

13-Valent pneumococcal protein conjugate vaccine; 23-Valent pneumococcal polysaccharide vaccine; Hemodialysis; Pneumonia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: J Infect Chemother Asunto de la revista: MICROBIOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2023 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Países Bajos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google